Non-pharmaceutical interventions to optimize cancer immunotherapy
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - September 29, 2023 Category: Cancer & Oncology Authors: Maximilian BoeschFlorent BatyFrank RassouliTobias KowatschMarkus JoergerMartin Fr ühMartin H. Brutschea Lung Center, Cantonal Hospital St.Gallen, St.Gallen, Switzerlandb Institute for Implementation Science in Health Care, University of Zurich, Zurich, S Source Type: research

Listeria-based vaccination against the pericyte antigen RGS5 elicits anti-vascular effects and colon cancer protection
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - September 28, 2023 Category: Cancer & Oncology Authors: Trevor S. AndersonAmanda L. McCormickElizabeth A. DaugherityMariam OladejoIzuchukwu F. OkpalanwakaSavanna L. SmithDuke AppiahLaurence M. WoodDevin B. Lowea Department of Immunotherapeutics and Biotechnology, Jerry H. Hodge School of Pharmacy, Texas Tech U Source Type: research

Digital spatial profiling of melanoma shows CD95 expression in immune cells is associated with resistance to immunotherapy
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - September 28, 2023 Category: Cancer & Oncology Authors: Sandra Martinez-MorillaMyrto MoutafiAileen I. FernandezShlomit JesselPrajan DivakarPok Fai WongRolando Garcia-MilianKurt A. SchalperHarriet M. KlugerDavid L. Rimma Department of Pathology, Yale School of Medicine, New Haven, CT, USAb Section of Medical On Source Type: research

PB101, a VEGF- and PlGF-targeting decoy protein, enhances antitumor immunity and suppresses tumor progression and metastasis
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - September 21, 2023 Category: Cancer & Oncology Authors: Eun-Jin GoHannah YangSeung Joon LeeHyun Gul YangJin A. ShinWon Suk LeeHye Seong LimHong Jae ChonChan Kima Medical Oncology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Gyeonggi-do, Republic of Koreab Laboratory of Translationa Source Type: research

CD40 agonism improves anti-tumor T cell priming induced by the combination of radiation therapy plus CTLA4 inhibition and enhances tumor response
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - September 15, 2023 Category: Cancer & Oncology Authors: Maud Charpentier Silvia Formenti Sandra Demaria Source Type: research

Chemoimmunotherapy triggers immune responses targeting microsatellite stable colorectal cancer
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - September 15, 2023 Category: Cancer & Oncology Authors: Marion Thibaudin Francois Ghiringhelli Source Type: research

Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - September 14, 2023 Category: Cancer & Oncology Authors: Annalisa Adamo Cristina Frusteri Sara Pilotto Simone Caligola Lorenzo Belluomini Ornella Poffe Luca Giacobazzi Silvia Dusi Chiara Musiu Yushu Hu Tian Wang Davide Rizzini Antonio Vella Stefania Can è Giulia Sartori Jessica Insolda Marco Sposito Ursula Ces Source Type: research

Homogeneity in immune features between colorectal liver metastases better identifies patients with good prognosis compared to pathological response to preoperative chemotherapy
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - September 14, 2023 Category: Cancer & Oncology Authors: David Henault David Stephen Pierre-Antoine St-Hilaire Nouredin Messaoudi Franck Vandenbroucke-Menu Eve Simoneau Zhixia Rong Maryl ène Plasse Richard L étourneau Andr é Roy Michel Dagenais R éal Lapointe Bich Nguyen Anne-Marie Mes-Masson G. Soucy Simon Source Type: research

In vitro vascular differentiation system efficiently produces natural killer cells for cancer immunotherapies
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - September 13, 2023 Category: Cancer & Oncology Authors: Yekaterina Galat Yuchen Du Mariana Perepitchka Xiao-Nan Li Irina V Balyasnikova William T Tse Svetlana Dambaeva Sylvia Schneiderman Philip M Iannaccone Oren Becher Douglas K Graham Vasiliy Galat Source Type: research

CAR-T cells dual-target CD123 and NKG2DLs to eradicate AML cells and selectively target immunosuppressive cells
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - August 26, 2023 Category: Cancer & Oncology Authors: Xin Jin Danni Xie Rui Sun Wenyi Lu Xia Xiao Yibing Yu Juanxia Meng Mingfeng Zhao Source Type: research

CD39+ conventional CD4+ T cells with exhaustion traits and cytotoxic potential infiltrate tumors and expand upon CTLA-4 blockade
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - August 18, 2023 Category: Cancer & Oncology Authors: Sabrina N. Bossio Carolina Abrate Jimena Tosello Boari Constanza Rodriguez Fernando P. Canale Mar ía C. Ramello Valentina Brunotto Wilfrid Richer Dario Rocha Christine Sedlik Anne Vincent-Salomon Edith Borcoman Andres Del Castillo Adriana Gruppi Elmer Fe Source Type: research

TNBC-derived Gal3BP/Gal3 complex induces immunosuppression through CD45 receptor
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - August 14, 2023 Category: Cancer & Oncology Authors: Annat Raiter Julia Lipovetsky Asaf Stenbac Ido Lubin Rinat Yerushalmi Source Type: research

Melanoma patients with immune-related adverse events after immune checkpoint inhibitors are characterized by a distinct immunological phenotype of circulating T cells and M-MDSCs
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - August 14, 2023 Category: Cancer & Oncology Authors: Alisa Lepper Rebekka Bitsch Feyza G ül Özbay Kurt Ihor Arkhypov Samantha Lasser Jochen Utikal Viktor Umansky Source Type: research

L-Kynurenine participates in cancer immune evasion by downregulating hypoxic signaling in T lymphocytes
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - August 10, 2023 Category: Cancer & Oncology Authors: Stephanie Schlichtner Inna M. Yasinska Elena Klenova Maryam Abooali Gurprit S. Lall Steffen M. Berger Sabrina Ruggiero Dietmar Cholewa Milan Milo šević Bernhard F. Gibbs Elizaveta Fasler-Kan Vadim V. Sumbayev Source Type: research

Group 2 innate lymphoid cells boost CD8+ T-cell activation in anti-tumor immune responses
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - August 9, 2023 Category: Cancer & Oncology Authors: Jing Wen Shipeng Cheng Ran Wang Yuying Huang Long Xu Liyan Ma Zhiyang Ling Jinfu Xu Deping Zhao Yaguang Zhang Bing Sun Source Type: research